Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status

ConclusionsThese results suggest thatIDH1 mutation may not be a prognostic factor for survival at the first progression of patients with ‘primary’ glioblastoma and pretreated ‘secondary’ glioblastoma, and further warrant investigation in prospective studies.
Source: Japanese Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research